EAMA
SRPT icon

EFG Asset Management (Americas)’s Sarepta Therapeutics SRPT Stock Holding History

EFG Asset Management (Americas)’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,933
Closed -$234K – 145
2023
Q3 		$234K Sell
1,933
-87
-4% -$9.83K 0.06% 133
2023
Q2 		$231K Buy
2,020
+282
+16% +$36.4K 0.05% 136
2023
Q1 		$240K Buy
1,738
+77
+5% +$9.99K 0.06% 130
2022
Q4 		$215K Buy
+1,661
New +$192K 0.05% 125
2021
Q1 		– Sell
-16,428
Closed -$2.8M – 150
2020
Q4 		$2.8M Sell
16,428
-3,602
-18% -$534K 0.57% 69
2020
Q3 		$2.81M Sell
20,030
-1,783
-8% -$271K 0.63% 59
2020
Q2 		$3.5M Sell
21,813
-2,790
-11% -$380K 0.91% 45
2020
Q1 		$2.41M Sell
24,603
-7,310
-23% -$836K 0.77% 52
2019
Q4 		$4.12M Buy
31,913
+11,812
+59% +$1.19M 1.09% 32
2019
Q3 		$1.51M Buy
20,101
+1,369
+7% +$162K 0.46% 69
2019
Q2 		$2.85M Buy
18,732
+3,631
+24% +$441K 0.81% 57
2019
Q1 		$1.8M Buy
+15,101
New +$1.94M 0.55% 67

Other funds holding SRPT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

EFG Asset Management (Americas)'s SRPT Position: Q4 2023 in Review

EFG Asset Management (Americas) sold out of Sarepta Therapeutics (SRPT) in Q4 2023, closing a stake of 1,933 shares — an estimated $234K sold.

EFG Asset Management (Americas) first reported a position in SRPT in Q1 2019 and held it in 12 quarters. The position peaked at $4.12M in Q4 2019. 395 funds tracked by Wall St. Rank hold SRPT as of Q4 2023.

  • EFG Asset Management (Americas) reported no remaining Sarepta Therapeutics position as of Q4 2023 after selling out during the quarter.
  • EFG Asset Management (Americas) sold 1,933 Sarepta Therapeutics shares in Q4 2023, an estimated $234K.
  • EFG Asset Management (Americas) first reported a position in Sarepta Therapeutics in Q1 2019 and held it in 12 quarters.
  • EFG Asset Management (Americas)'s Sarepta Therapeutics position peaked at $4.12M in Q4 2019.
  • 395 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q4 2023.

Based on EFG Asset Management (Americas)'s 13F filing for Q4 2023, filed 1 Feb 2024.